Print Page  Close Window


SEC Filings

S-1/A
OREXIGEN THERAPEUTICS, INC. filed this Form S-1/A on 02/16/2007
Entire Document
 
 

TABLE OF CONTENTS
(continued)
                     
                Page
      5.4    
REMOVAL AND RESIGNATION OF OFFICERS
    11  
      5.5    
VACANCIES IN OFFICES
    11  
      5.6    
REPRESENTATION OF SHARES OF OTHER CORPORATIONS
    11  
      5.7    
AUTHORITY AND DUTIES OF OFFICERS
    11  
           
 
     
ARTICLE VI — RECORDS AND REPORTS     11  
      6.1    
MAINTENANCE AND INSPECTION OF RECORDS
    11  
      6.2    
INSPECTION BY DIRECTORS
    12  
           
 
     
ARTICLE VII — GENERAL MATTERS     12  
      7.1    
EXECUTION OF CORPORATE CONTRACTS AND INSTRUMENTS
    12  
      7.2    
STOCK CERTIFICATES; PARTLY PAID SHARES
    12  
      7.3    
SPECIAL DESIGNATION ON CERTIFICATES
    13  
      7.4    
LOST CERTIFICATES
    13  
      7.5    
CONSTRUCTION; DEFINITIONS
    13  
      7.6    
DIVIDENDS
    13  
      7.7    
FISCAL YEAR
    14  
      7.8    
SEAL
    14  
      7.9    
TRANSFER OF STOCK
    14  
      7.10    
STOCK TRANSFER AGREEMENTS
    14  
      7.11    
REGISTERED STOCKHOLDERS
    14  
      7.12    
WAIVER OF NOTICE
    14  
           
 
     
ARTICLE VIII — NOTICE BY ELECTRONIC TRANSMISSION     15  
      8.1    
NOTICE BY ELECTRONIC TRANSMISSION
    15  
      8.2    
DEFINITION OF ELECTRONIC TRANSMISSION
    16  
      8.3    
INAPPLICABILITY
    16  
           
 
     
ARTICLE IX — INDEMNIFICATION     16  
      9.1    
INDEMNIFICATION OF DIRECTORS AND OFFICERS
    16  
      9.2    
INDEMNIFICATION OF OTHERS
    16  
      9.3    
PREPAYMENT OF EXPENSES
    16  
      9.4    
DETERMINATION; CLAIM
    17  
      9.5    
NON-EXCLUSIVITY OF RIGHTS
    17  
      9.6    
INSURANCE
    17  
      9.7    
OTHER INDEMNIFICATION
    17  
      9.8    
AMENDMENT OR REPEAL
    17  
           
 
     
ARTICLE X — AMENDMENTS     17  

-ii-